Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
49,092,800
-
Share change
-
-6,154,350
-
Total reported value
-
$176,403,697
-
Put/Call ratio
-
247%
-
Price per share
-
$3.59
-
Number of holders
-
100
-
Value change
-
-$25,051,894
-
Number of buys
-
32
-
Number of sells
-
61
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q1 2022
As of 31 Mar 2022,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,092,800 shares.
The largest 10 holders included
Indaba Capital Management, L.P., BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, Neuberger Berman Group LLC, VANGUARD GROUP INC, NEEDHAM INVESTMENT MANAGEMENT LLC, MORGAN STANLEY, BOOTHBAY FUND MANAGEMENT, LLC, Nuveen Asset Management, LLC, and STATE STREET CORP.
This page lists
100
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.